Literature DB >> 18433959

Renal clearance parameters for PBPK model analysis of early lifestage differences in the disposition of environmental toxicants.

Robert S DeWoskin1, Chad M Thompson.   

Abstract

Physiologically-based pharmacokinetic (PBPK) models are being developed to evaluate whether humans in early life are more or less susceptible to adverse effects than adults from exposure to chemicals because of reduced renal clearance. To support the development of such models, data on the rates of glomerular filtration, tubular secretion, tubular reabsorption, and renal blood flow in neonates and infants were compiled and summarized. All three processes are deficient in the newborn with varying maturation rates during the first months and years of life. Glomerular filtration rate (GFR) has traditionally been the primary indicator of kidney function, and in full-term neonates (<1-month-old) is about 30% of the adult level, subsequently approaching adult rates between 6 months and 1 year of age. Tubular secretion is around 25% of adult levels at birth, and increases more slowly and more variably than GFR, not approaching adult levels until 1-5 years of age. Limited data on renal plasma flow indicate neonatal rates of only 10-20% of adult values that rapidly increase to 50% by 6 months, and then approach adult levels by 1-2 years of age. Examples of PBPK model representations of renal clearance for chemicals that are primarily cleared by the kidneys are discussed in terms of their use in evaluating early life stage susceptibility.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18433959     DOI: 10.1016/j.yrtph.2008.02.005

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  6 in total

1.  A physiologically based pharmacokinetic model for capreomycin.

Authors:  B Reisfeld; C P Metzler; M A Lyons; A N Mayeno; E J Brooks; M A Degroote
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

Review 2.  Key to Opening Kidney for In Vitro-In Vivo Extrapolation Entrance in Health and Disease: Part I: In Vitro Systems and Physiological Data.

Authors:  Daniel Scotcher; Christopher Jones; Maria Posada; Amin Rostami-Hodjegan; Aleksandra Galetin
Journal:  AAPS J       Date:  2016-06-30       Impact factor: 4.009

3.  Pharmacodynamic model of sodium-glucose transporter 2 (SGLT2) inhibition: implications for quantitative translational pharmacology.

Authors:  Tristan S Maurer; Avijit Ghosh; Nahor Haddish-Berhane; Aarti Sawant-Basak; Carine M Boustany-Kari; Li She; Michael T Leininger; Tong Zhu; Meera Tugnait; Xin Yang; Emi Kimoto; Vincent Mascitti; Ralph P Robinson
Journal:  AAPS J       Date:  2011-08-26       Impact factor: 4.009

4.  An assessment of the interindividual variability of internal dosimetry during multi-route exposure to drinking water contaminants.

Authors:  Mathieu Valcke; Kannan Krishnan
Journal:  Int J Environ Res Public Health       Date:  2010-11-17       Impact factor: 3.390

5.  Developmental allometry and paediatric malaria.

Authors:  Erica M W Billig; Wendy P O'Meara; Eleanor M Riley; F Ellis McKenzie
Journal:  Malar J       Date:  2012-03-06       Impact factor: 2.979

6.  The Influence of Drug Properties and Ontogeny of Transporters on Pediatric Renal Clearance through Glomerular Filtration and Active Secretion: a Simulation-Based Study.

Authors:  Sînziana Cristea; Elke Henriëtte Josephina Krekels; Amin Rostami-Hodjegan; Karel Allegaert; Catherijne Annette Jantine Knibbe
Journal:  AAPS J       Date:  2020-06-21       Impact factor: 4.009

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.